X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51553) 51553
Newsletter (8950) 8950
Publication (3249) 3249
Newspaper Article (1149) 1149
Book Review (551) 551
Book Chapter (439) 439
Magazine Article (299) 299
Conference Proceeding (159) 159
Transcript (96) 96
Book / eBook (74) 74
Trade Publication Article (62) 62
Dissertation (39) 39
Web Resource (32) 32
Paper (8) 8
Data Set (7) 7
Reference (4) 4
Streaming Video (4) 4
Report (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36911) 36911
atrial fibrillation (36301) 36301
male (20682) 20682
index medicus (20077) 20077
female (19695) 19695
cardiac & cardiovascular systems (17542) 17542
aged (16591) 16591
middle aged (14907) 14907
atrial fibrillation - drug therapy (11664) 11664
stroke (10592) 10592
risk factors (9555) 9555
atrial-fibrillation (8594) 8594
atrial fibrillation - therapy (8068) 8068
treatment outcome (7913) 7913
anticoagulants (7821) 7821
research (7706) 7706
warfarin (7640) 7640
care and treatment (7185) 7185
atrial fibrillation - complications (6840) 6840
adult (6624) 6624
anticoagulants - therapeutic use (6254) 6254
atrial fibrillation - physiopathology (5973) 5973
aged, 80 and over (5936) 5936
electrocardiography (5721) 5721
heart (5706) 5706
drug therapy (5601) 5601
prevention (5413) 5413
cardiac arrhythmia (5356) 5356
medical research (4937) 4937
risk (4685) 4685
medicine, experimental (4671) 4671
cardiology (4539) 4539
mortality (4535) 4535
anti-arrhythmia agents - therapeutic use (4525) 4525
catheter ablation (4390) 4390
therapy (4311) 4311
stroke - prevention & control (4254) 4254
medicine, general & internal (4229) 4229
atrial fibrillation - diagnosis (4143) 4143
management (4116) 4116
cardiovascular (4054) 4054
analysis (3951) 3951
reports (3906) 3906
heart failure (3861) 3861
fibrillation (3771) 3771
follow-up studies (3750) 3750
peripheral vascular disease (3662) 3662
time factors (3567) 3567
retrospective studies (3518) 3518
abridged index medicus (3512) 3512
ablation (3429) 3429
anticoagulation (3247) 3247
prospective studies (3185) 3185
anticoagulants - administration & dosage (3154) 3154
atrial fibrillation - etiology (3149) 3149
anticoagulants - adverse effects (3109) 3109
arrhythmia (3097) 3097
cardiac patients (3040) 3040
stroke - etiology (3012) 3012
atrial fibrillation - epidemiology (3006) 3006
animals (2945) 2945
electric countershock (2914) 2914
atrial fibrillation - surgery (2904) 2904
prognosis (2768) 2768
warfarin - therapeutic use (2759) 2759
administration, oral (2729) 2729
surgery (2683) 2683
risk assessment (2642) 2642
dabigatran (2622) 2622
pharmacology & pharmacy (2601) 2601
health aspects (2599) 2599
thromboembolism (2468) 2468
patients (2450) 2450
prevalence (2414) 2414
cardiovascular diseases (2370) 2370
recurrence (2367) 2367
medicine & public health (2329) 2329
incidence (2202) 2202
stroke prevention (2112) 2112
hypertension (2090) 2090
aspirin (2031) 2031
echocardiography (2018) 2018
internal medicine (2018) 2018
hematology (2000) 2000
antithrombotic therapy (1925) 1925
hemorrhage - chemically induced (1917) 1917
usage (1900) 1900
heart-failure (1875) 1875
efficacy (1822) 1822
rivaroxaban (1814) 1814
risk-factors (1806) 1806
cardiovascular disease (1779) 1779
sinus rhythm (1746) 1746
clinical trials (1745) 1745
universities and colleges (1730) 1730
trial (1680) 1680
atrial fibrillation - prevention & control (1673) 1673
catheter ablation - methods (1640) 1640
complications and side effects (1630) 1630
patient outcomes (1628) 1628
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (56929) 56929
German (1561) 1561
Russian (752) 752
French (740) 740
Spanish (711) 711
Italian (487) 487
Japanese (366) 366
Polish (240) 240
Chinese (151) 151
Portuguese (136) 136
Czech (72) 72
Hungarian (72) 72
Turkish (70) 70
Swedish (64) 64
Dutch (56) 56
Danish (48) 48
Norwegian (34) 34
Romanian (32) 32
Finnish (28) 28
Korean (26) 26
Hebrew (25) 25
Croatian (24) 24
Slovak (17) 17
Serbian (12) 12
Lithuanian (9) 9
Ukrainian (9) 9
Bulgarian (8) 8
Icelandic (4) 4
Bosnian (2) 2
Greek (2) 2
Persian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Belarusian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, Current cadiovascular therapy, ISBN 9781447154754
Web Resource
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 16, pp. 2088 - 2095
Abstract Atrial fibrillation (AF) is an all-too-common and often challenging reality of clinical care. AF leads to significant morbidity and mortality;... 
Cardiovascular | Internal Medicine | microRNAs | gene therapy | genetic predisposition to disease | antagomirs | action potentials | genetic loci | Heart | Analysis | Atrial fibrillation | Mortality | Therapeutics | Homeopathy | Materia medica and therapeutics
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2017, Volume 69, Issue 16, pp. 2088 - 2095
Atrial fibrillation (AF) is an all-too-common and often challenging reality of clinical care. AF leads to significant morbidity and mortality; however,... 
microRNAs | gene therapy | genetic predisposition to disease | antagomirs | action potentials | genetic loci | PULMONARY VEINS | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | MECHANISMS | SUPPRESSION | TRIAL | ELECTROPHYSIOLOGY | SUBSTRATE | POSTERIOR LEFT ATRIUM | LEADS | PROPAGATION | Atrial Fibrillation - etiology | Genetic Therapy | Atrial Fibrillation - therapy | Humans | Heart | Atrial fibrillation | Mortality | Genes | Genomics | Transforming growth factors | Population genetics | Homeopathy | Materia medica and therapeutics | Anopheles | MicroRNA | Analysis | Therapeutics | Conduction | Substance abuse treatment | Clarithromycin | Arrhythmia | Inactivation | Incidence | Proteins | Alterations | Genetics | Membrane potential | Calcium homeostasis | Architecture | Abnormalities | Gap junctions | Maintenance | Patients | Ablation | Sodium | Calcium channels (L-type) | Myocardium | Gene therapy | Circulation | Drugs | Cardiac arrhythmia | Drug abuse | Propagation | Calcium | Toxicity | Medical services | Homeostasis | Clinical trials | Action potential | Stimulation | Electrical insulation | Genomes | Congestive heart failure | Heterogeneity | Veins | Rodents | Modulation | Dementia disorders | Ion channels | Safety | Age | Hum | Atrium | Stroke | Automation | Effectiveness | Calcium (intracellular) | Diabetes mellitus | Medical instruments | Cardiomyocytes | Calpain | Pharmacology | Ribonucleic acid--RNA | Velocity | Morbidity | MicroRNAs | Genetic engineering | Potassium | Parasympathetic nervous system | Veins & arteries | Apoptosis
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 07/2019, Volume 287, pp. 155 - 161
Atrial fibrillation (AF) is a complex cardiac arrhythmia with diverse etiology that negatively affects morbidity and mortality of millions of patients.... 
Arrhythmia mechanisms | Antiarrhythmic drugs | Computational modeling | Atrial fibrillation | Catheter ablation | COST-EFFECTIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | POPULATIONS | MECHANISMS | VARIABILITY | ELECTROPHYSIOLOGY | SIMULATIONS | TERMINATION | SINUS RHYTHM | INSIGHTS
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Europace, ISSN 1099-5129, 10/2010, Volume 12, Issue 10, pp. 1360 - 1420
Rhythm control | CARDIAC & CARDIOVASCULAR SYSTEMS | Atrial fibrillation | LONG-TERM SURVIVAL | Anticoagulation | II RECEPTOR BLOCKADE | Upstream therapy | RADIOFREQUENCY CATHETER ABLATION | ANGIOTENSIN-CONVERTING ENZYME | Guidelines | Rate control | ANTIARRHYTHMIC-DRUG THERAPY | PARKINSON-WHITE-SYNDROME | European Society of Cardiology | Left atrial ablation | CARDIAC RESYNCHRONIZATION THERAPY | PULMONARY-VEIN ISOLATION | POLYUNSATURATED FATTY-ACIDS | CONGESTIVE-HEART-FAILURE | Pulmonary vein isolation | Prevalence | Humans | Middle Aged | Wolff-Parkinson-White Syndrome - epidemiology | Male | Atrial Fibrillation - physiopathology | Heart Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Heart Valve Diseases - epidemiology | Fibrinolytic Agents - therapeutic use | Heart Rate - physiology | Female | Hyperthyroidism - epidemiology | Atrial Fibrillation - diagnosis | Platelet Aggregation Inhibitors - therapeutic use | Heart Failure - epidemiology | Electric Countershock - methods | Acute Coronary Syndrome - epidemiology | Athletes - statistics & numerical data | Comorbidity | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anti-Arrhythmia Agents - therapeutic use | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Pregnancy | Atrial Fibrillation - epidemiology | Electric Countershock - instrumentation | Diabetes Mellitus - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Atrial Fibrillation - etiology | Acute Coronary Syndrome - therapy | Heart Valve Diseases - therapy | Aged | Cardiomyopathy, Hypertrophic - epidemiology | Lung Diseases - epidemiology | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 546S - 592S
Journal Article